1. Home
  2. HTZ vs NRIX Comparison

HTZ vs NRIX Comparison

Compare HTZ & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hertz Global Holdings Inc

HTZ

Hertz Global Holdings Inc

HOLD

Current Price

$7.01

Market Cap

1.6B

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$16.72

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTZ
NRIX
Founded
1918
2009
Country
United States
United States
Employees
26000
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HTZ
NRIX
Price
$7.01
$16.72
Analyst Decision
Hold
Strong Buy
Analyst Count
4
12
Target Price
$4.93
$30.50
AVG Volume (30 Days)
10.3M
1.3M
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$5.00
N/A
Revenue Next Year
$3.61
$40.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
99.31
52 Week Low
$3.78
$8.20
52 Week High
$9.39
$22.50

Technical Indicators

Market Signals
Indicator
HTZ
NRIX
Relative Strength Index (RSI) 72.67 58.77
Support Level $4.94 $16.02
Resistance Level $7.35 $16.71
Average True Range (ATR) 0.54 0.92
MACD 0.20 0.18
Stochastic Oscillator 92.60 82.73

Price Performance

Historical Comparison
HTZ
NRIX

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through its Hertz, Dollar and Thrifty brands. The company has two reportable segments: i) Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean, ii) International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The company maintains a substantial network of company-operated rental locations, a majority of which are in Europe, and has franchisees and partners that operate rental locations under brands. Geographical markets include North America, Europe, Pacific Asia, Middle East and Africa, and Latin America.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: